Air pollution, inhaled therapy and COPD exacerbations in Yunlin, Taiwan: a 2016–2024 single-centre retrospective cohort with environmental and carbon-footprint analyses
Chung-Yu Chen, Ling-Yu Huang, Bor-Wen Cheng · 2025
Read Air pollution, inhaled therapy and COPD exacerbations in Yunlin, Taiwan: a 2016–2024 single-centre retrospective cohort with environmental and carbon-footprint analyses by Chung-Yu Chen, Ling-Yu Huang, Bor-Wen Cheng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12716513.txt.
Description
Chen, Huang, and Cheng study how air pollution, inhaler choice, and flare-ups of chronic lung disease interact in one Taiwanese hospital's records from 2016 to 2024. Pollution is known to worsen COPD, while the pressurized inhalers many patients use release greenhouse gases. The team linked visit records with local pollution data and estimated the carbon cost of each inhaler type. They modeled how drug choices and dirty air each related to flare-up rates.
Higher fine-particle pollution tracked with more flare-ups, while triple therapy tracked with fewer. Heavy use of rescue inhalers signaled poorer control. When greener inhaler types rose in 2020 and 2021, hospital stays and emissions both fell. A later swing back to pressurized inhalers coincided with more flare-ups and a bigger footprint. The authors argue that prescribing can serve lungs and climate at once, if the greener devices are chosen when they fit the patient.
Catalog record
| CREATOR | Chung-Yu Chen, Ling-Yu Huang, Bor-Wen Cheng |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |